2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol manufacturers
- LDL-IN-3
-
- $388.00
-
2026-05-16
- CAS:180908-67-2
- Purity: 99.75%
- Supply Ability: 10g
- LDL-IN-3
-
- $388.00
-
2026-05-15
- CAS:180908-67-2
- Purity: 99.75%
- Supply Ability: 10g
- LDL-IN-3
-
- $388.00
-
2026-05-15
- CAS:180908-67-2
- Purity: 99.75%
- Supply Ability: 10g
|
| | 2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol Basic information |
| | 2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol Chemical Properties |
| Boiling point | 476.0±45.0 °C(Predicted) | | density | 1.02±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 13.11±0.40(Predicted) |
| | 2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol Usage And Synthesis |
| Uses | LDL-IN-3 is an anti-atherosclerotic compound extracted from patent WO/2005/039596A1, example C25 and patent US 6133467, example 3. | | in vivo | LDL-IN-3 decreases serum cholesterol, TBARS and the amount of aortic lesions (57 %) in comparison with control rabbits. LDL-IN-3 is found in very high concentrations in the serum (182.4 μg/mL) and livers (323 μg/mL)[1][2]. | | References | [1] WO/2005/039596A1 [2] US 6133467 |
| | 2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol Preparation Products And Raw materials |
|